BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 171652)

  • 21. Regulation of adrenal ornithine decarboxylase by adrenocorticotropic hormone and cyclic AMP.
    Richman R; Dobbins C; Voina S; Underwood L; Mahaffee D; Gitelman ; Van Wyk J; Ney RL
    J Clin Invest; 1973 Aug; 52(8):2007-15. PubMed ID: 4352578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine inhibits cyclic AMP-dependent protein kinase and ornithine decarboxylase activities in neuroblastoma X glioma hybrid cells.
    Bachrach U; Benalal D; Reches A
    Life Sci; 1979 Nov; 25(22):1879-83. PubMed ID: 231167
    [No Abstract]   [Full Text] [Related]  

  • 23. Cycloheximide potentiation of prostaglandin E1- and cholera toxin-stimulated cyclic AMP accumulation in NG108-CC15 neuroblastoma-glioma hybrid cells.
    Moylan RD; Brooker G
    J Biol Chem; 1981 Jul; 256(13):6573-6. PubMed ID: 6263920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP-dependent regulation of ornithine decarboxylase activity in Chinese hamster ovary cells maintained with a salts/glucose medium.
    Costa M
    J Cyclic Nucleotide Res; 1978 Oct; 4(5):375-87. PubMed ID: 214473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanism of ACTH stimulation of adrenal ornithine decarboxylase activity.
    Levine JH; Nicholson WE; Peytremann A; Orth DN
    Endocrinology; 1975 Jul; 97(1):136-44. PubMed ID: 166825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on regulatory factors of ornithine decarboxylase activity during development of mouse mammary epithelium in vitro.
    Oka T; Perry JW
    J Biol Chem; 1976 Mar; 251(6):1738-44. PubMed ID: 176159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of thyroid ornithine ornithine decarboxylase (ODC) by thyrotropin. I. The rat.
    Richman R; Park S; Akbar M; Yu S; Burke G
    Endocrinology; 1975 Jun; 96(6):1403-12. PubMed ID: 165059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of ornithine decarboxylase in cultured mouse L cells. II. Effects of additions of amino acids and serum.
    Yamasaki Y; Ichihara A
    J Biochem; 1977 Feb; 81(2):461-5. PubMed ID: 191444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro regulation of ornithine decarboxylase in dog thyroid slices.
    Mockel J; Decaux G; Unger J; Dumont JE
    Endocrinology; 1980 Dec; 107(6):2069-75. PubMed ID: 6159206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor stimulation of ornithine decarboxylase activity in a human hepatoma cell line.
    Moriarity DM; DiSorbo DM; Litwack G; Savage CR
    Proc Natl Acad Sci U S A; 1981 May; 78(5):2752-6. PubMed ID: 6265908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nerve growth factor-mediated selective induction of ornithine decarboxylase in rat pheochromocytoma; a cyclic AMP-independent process.
    Hatanaka H; Otten U; Thoenen H
    FEBS Lett; 1978 Aug; 92(2):313-6. PubMed ID: 212301
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-2-Adrenergic stimulation of ornithine decarboxylase activity in porcine granulosa cells in vitro.
    Veldhuis JD; Harrison TS; Hammond JM
    Biochim Biophys Acta; 1980 Jan; 627(2):123-30. PubMed ID: 6153144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cAMP in the induction of ornithine decarboxylase by nerve and epidermal growth factors.
    LaCorbiere M; Schubert D
    J Neurosci Res; 1981; 6(2):211-6. PubMed ID: 6264091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional and translational control of nafenopin-induced ornithine decarboxylase activity in rat liver.
    Lam DC; Levine WG
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):113-22. PubMed ID: 7394309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opiates and cultured neuroblastoma x glioma cells. Effect on cyclic AMP and polyamine levels and on ornithine decarboxylase and protein kinase activities.
    Benalal D; Bachrach U
    Biochem J; 1985 Apr; 227(2):389-95. PubMed ID: 2988499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ornithine decarboxylase induction during B1 progression of normal and Rous sarcoma virus-transformed cells.
    Haddox MK; Magun BE; Russell DH
    Cancer Res; 1980 Mar; 40(3):604-8. PubMed ID: 6258784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine decarboxylase activities.
    Insel PA; Fenno J
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):862-5. PubMed ID: 204937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butyrate-induced increase in neuron-specific enolase and ornithine decarboxylase in anaplastic glioma cells.
    Vinores SA; Marangos PJ; Ko L
    Brain Res; 1982 Sep; 281(1):23-8. PubMed ID: 7139340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forskolin induction of S-100 protein in glioma and hybrid cells.
    Higashida H; Sano M; Kato K
    J Cell Physiol; 1985 Jan; 122(1):39-44. PubMed ID: 4038402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of 3':5'-cyclic AMP-dependent protein kinase and induction of ornithine decarboxylase as early events in induction of mixed-function oxygenases.
    Byus CV; Costa M; Sipes IG; Brodie BB; Russell DH
    Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1241-5. PubMed ID: 177981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.